Company TaiGen Biopharmaceuticals Holdings Limited
Equities
4157
KYG866171005
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
15.6 TWD | -0.32% | +3.65% | +2.63% |
Business Summary
Sales per Business
TWD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Development of Innovative New Drugs
96.8
%
| 36 | 100.0 % | 119 | 96.8 % | +228.87% |
Other
3.2
%
| - | - | 4 | 3.2 % | - |
Sales per region
TWD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
75.2
%
| 0 | 0.0 % | 93 | 75.2 % | - |
Taiwan
24.8
%
| 21 | 58.0 % | 31 | 24.8 % | +45.36% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Philip Huang
CEO | Chief Executive Officer | - | 18-12-16 |
Richard Lue
DFI | Director of Finance/CFO | - | 16-03-31 |
Ming-Chu Hsu
BRD | Director/Board Member | - | 01-03-31 |
Hsuan Ju Wang
IRC | Investor Relations Contact | - | - |
MIng Tsung Kao
AUD | Comptroller/Controller/Auditor | - | 19-12-15 |
Chu Chung Lin
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Shou-Chuan Ho
BRD | Director/Board Member | - | 13-04-28 |
Hong Jen Chang
BRD | Director/Board Member | 68 | 13-03-31 |
Sheng Fu Yu
BRD | Director/Board Member | 79 | 19-06-11 |
Weng Foung Huang
BRD | Director/Board Member | - | 11-06-23 |
Kuo-Hsi Wang
BRD | Director/Board Member | - | 09-03-02 |
Ming-Chu Hsu
BRD | Director/Board Member | - | 01-03-31 |
Philip Huang
CEO | Chief Executive Officer | - | 18-12-16 |
Yen Hua Huang
BRD | Director/Board Member | - | 07-12-30 |
Yeh Hung Chang
BRD | Director/Board Member | - | 19-06-11 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 717,844,175 | 358,926,175 ( 50.00 %) | 0 | 50.00 % |
Company contact information
TaiGen Biopharmaceuticals Holdings Ltd.
7th Floor No. 138 Shinming Road
114 70, Taipei
+
http://www.taigenbiotech.comSector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
+2.63% | 348M | |
+8.63% | 115B | |
+13.17% | 107B | |
-12.76% | 22.31B | |
-3.99% | 21.6B | |
-7.19% | 18.23B | |
-39.93% | 17.62B | |
+6.67% | 14.26B | |
+33.90% | 12.37B | |
-28.60% | 8.28B |
- Stock Market
- Equities
- 4157 Stock
- Company TaiGen Biopharmaceuticals Holdings Limited